Zimmer Biomet Robotics

Alcon Showcases Cloud-based Planning and World-class Digital Technologies During AAO 2023

Retrieved on: 
星期一, 十月 30, 2023

Ophthalmologists, surgical staff, researchers, and industry leaders will have the opportunity to experience Alcon’s latest digital offerings and participate in additional Alcon events during the conference.

Key Points: 
  • Ophthalmologists, surgical staff, researchers, and industry leaders will have the opportunity to experience Alcon’s latest digital offerings and participate in additional Alcon events during the conference.
  • Alcon AAO event information and registration is available at MyAlconatAAO.com .
  • With the full, U.S. commercial availability of SMARTCataract, Alcon furthers its position as a leader in surgical ophthalmology.
  • For more information about the Alcon products and services on display at AAO, please visit MyAlconatAAO.com .

Alcon Announces Largest-Ever Scientific Presence at ASCRS 2023 and Expands Image-Guided Connectivity

Retrieved on: 
星期一, 五月 1, 2023

Alcon ASCRS event information and registration is available at MyAlconatASCRS.com .

Key Points: 
  • Alcon ASCRS event information and registration is available at MyAlconatASCRS.com .
  • “The pace of innovation happening across eye care is extraordinary, and as the industry leader, we are excited to be leading the charge at ASCRS 2023,” said Sergio Duplan, President, North America at Alcon.
  • evaluates a head-to-head comparison of distance and intermediate vision of Clareon monofocal IOL and TECNIS Eyhance* monofocal IOL.
  • For information on Alcon events and news at ASCRS, please visit MyAlconatASCRS.com .

Alcon Unveils Latest Evolution of Cataract Integration and Connectivity at AAO 2021

Retrieved on: 
星期一, 十一月 8, 2021

This new platform furthers Alcons leadership in clinic-to-operating room (OR) integration with image-guided technologies and cloud-based planning.

Key Points: 
  • This new platform furthers Alcons leadership in clinic-to-operating room (OR) integration with image-guided technologies and cloud-based planning.
  • SMARTCataract to be Showcased to U.S. Ophthalmologists at AAO 2021
    Alcon will conduct live demos of SMARTCataract, the first application under Alcons SMART Solutions platform .
  • Alcon plans to roll out additional connectivity in the OR with the ORA SYSTEM and NGENUITY 3D Visualization System in the near future.
  • Alcon is expanding to additional customers in the U.S. through the end of the year, with a broader rollout in 2022.

Global Knee Replacement Market Report 2021-2027: Leading Players are Smith & Nephew, Stryker, J&J, Zimmer Biomet, B. Braun Melsungen, MicroPort Scientific, Integra Life Sciences, Conformis - ResearchAndMarkets.com

Retrieved on: 
星期二, 八月 3, 2021

The "Knee Replacement Market Global Forecast Industry Trends, Growth, Opportunity By Products, Regions, Company Analysis" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Knee Replacement Market Global Forecast Industry Trends, Growth, Opportunity By Products, Regions, Company Analysis" report has been added to ResearchAndMarkets.com's offering.
  • Knee replacement is a surgical procedure that minimizes pain and enhances the quality of life in patients with severe arthritis.
  • Developed countries, such as the United States and Germany, have a significant market share in the knee replacement business worldwide.
  • In 2021, Zimmer Biomet Holdings, Inc., announced the ROSA Partial Knee System for robotically-assisted partial knee replacement surgeries.

Veranex Announces Acquisition of Experien Group

Retrieved on: 
星期二, 八月 3, 2021

Veranex , the first concept-to-commercialization global service provider dedicated to the medtech industry, today announced the acquisition of Experien Group, a leading provider of a full range of regulatory, quality, and clinical consulting services to medtech companies.

Key Points: 
  • Veranex , the first concept-to-commercialization global service provider dedicated to the medtech industry, today announced the acquisition of Experien Group, a leading provider of a full range of regulatory, quality, and clinical consulting services to medtech companies.
  • We are excited to welcome Experien Group to Veranex, said David Dockhorn , CEO of Veranex.
  • With this acquisition, Veranex adds the premier provider of regulatory, quality, and clinical consulting services to medtech companies.
  • Experien Group adds another layer of value and medtech insight to Veranex, said Veranex Executive Chairman Pat Donnelly .

Pulmonx Welcomes Two New Board Members, Adding Expertise in Health Technology, Consumer Marketing, and Integrated Healthcare Delivery Networks

Retrieved on: 
星期一, 八月 2, 2021

Alissa Hsu Lynch is the Global Lead of MedTech Strategy and Solutions for Google Cloud where she works with Fortune 500 customers to transform healthcare through technology.

Key Points: 
  • Alissa Hsu Lynch is the Global Lead of MedTech Strategy and Solutions for Google Cloud where she works with Fortune 500 customers to transform healthcare through technology.
  • Previously she was a global executive for more than 20 years at Johnson & Johnson working in medtech, consumer marketing, strategy, and general management.
  • Ms. Lynch received an M.B.A in General Management from Columbia University and an A.B.
  • We are thrilled to have Alissa and Tiffany join the Pulmonx Board of Directors.

Baxter to Present at UBS Genomics 2.0 and MedTech Innovations Summit

Retrieved on: 
星期四, 七月 29, 2021

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the UBS Genomics 2.0 and MedTech Innovations Summit on Thursday, August 12, 2021 in Laguna Beach, Calif. Jay Saccaro, Baxters chief financial officer, is scheduled to present at 10:00 a.m. Pacific Time.

Key Points: 
  • Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the UBS Genomics 2.0 and MedTech Innovations Summit on Thursday, August 12, 2021 in Laguna Beach, Calif. Jay Saccaro, Baxters chief financial officer, is scheduled to present at 10:00 a.m. Pacific Time.
  • The live webcast of Baxters presentation can be accessed at www.baxter.com and will be available for replay through August 11, 2022.
  • Every day, millions of patients and caregivers rely on Baxters leading portfolio of critical care, nutrition, renal, hospital and surgical products.
  • For more than 85 years, weve been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen.

Aurora Spine Corporation to Participate in Alliance Global Partners Virtual MedTech Summer Conference

Retrieved on: 
星期三, 七月 28, 2021

CARLSBAD, Calif., July 28, 2021 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (Aurora Spine or the Company) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced its management team will be participating in Alliance Global Partners Virtual MedTech Summer Conference on Thursday, July 29, 2021.

Key Points: 
  • CARLSBAD, Calif., July 28, 2021 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (Aurora Spine or the Company) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced its management team will be participating in Alliance Global Partners Virtual MedTech Summer Conference on Thursday, July 29, 2021.
  • Mr. Trent Northcutt, President and Chief Executive Officer of Aurora Spine, stated, We are grateful to Alliance Global Partners for including Aurora Spine in their MedTech Conference.
  • We are looking forward to presenting the Aurora Spine story to interested MedTech investors.
  • Investors that are interested in arranging a meeting with the management team of Aurora Spine should contact their Alliance Global Partners representative or email [email protected] .

NeuroOne to Participate in Alliance Global Partners (A.G.P.) Virtual MedTech Summer Conference on July 29, 2021

Retrieved on: 
星期三, 七月 28, 2021

EDEN PRAIRIE, Minn., July 28, 2021 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) (NeuroOne or the Company), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announces today that the Company will participate in Alliance Global Partners (A.G.P.)

Key Points: 
  • EDEN PRAIRIE, Minn., July 28, 2021 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) (NeuroOne or the Company), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announces today that the Company will participate in Alliance Global Partners (A.G.P.)
  • Virtual MedTech Summer Conference on July 29, 2021.
  • The event will consist of one-on-one virtual investor meetings.
  • Investors participating in the virtual conference who are interested in meeting with management should contact their A.G.P.

Vyant Bio to Present at A.G.P.’s Virtual MedTech Summer Conference

Retrieved on: 
星期二, 七月 27, 2021

CHERRY HILL, N.J., July 27, 2021 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (Vyant Bio, Company) (Nasdaq: VYNT), an emerging leader in novel drug discovery, is pleased to announce that Jay Roberts, Chief Executive Officer, will present at A.G.P.s Virtual MedTech Summer Conference hosted by Alliance Global Partners (A.G.P) on Thursday, July 29, 2021.

Key Points: 
  • CHERRY HILL, N.J., July 27, 2021 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (Vyant Bio, Company) (Nasdaq: VYNT), an emerging leader in novel drug discovery, is pleased to announce that Jay Roberts, Chief Executive Officer, will present at A.G.P.s Virtual MedTech Summer Conference hosted by Alliance Global Partners (A.G.P) on Thursday, July 29, 2021.
  • For questions and inquiries regarding the conference or to register for a one-on-one meeting, please contact a registered A.G.P.
  • Vyant Bio will also be available for outside virtual 1:1 meetings both during and after A.G.Ps Virtual MedTech Summer Conference.
  • Vyant Bio, Inc. (Vyant Bio, the Company) (Nasdaq: VYNT) is emerging as an advanced biotechnology drug discovery company.